Myskowski, Patricia
Memorial Sloan Kettering Cancer Center
2 papers on CoChatORCID 0000-0001-6903-3335
Most cited papers
- Verified
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results
Duvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A. G., Myskowski, P., Crowley, C., Yocum, R. C., & for Members of the Bexarotene Worldwide Study Group (2001) · Journal of Clinical Oncology
Cutaneous lymphoproliferative disorders researchNonmelanoma Skin Cancer Studies
Cited by 706
- Verified
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
Horwitz, S. M., Koch, R., Porcu, P., Oki, Y., Moskowitz, A., Perez, M., Myskowski, P., Officer, A., Jaffe, J. D., Morrow, S. N., et al. (2018) · Blood
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 290
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free